Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients

References

• James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014 Feb 05; 311(5): 507–20.
   PubMed Web of Science ®Google Scholar
• Mehta R, Pe D. Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? Curr Hypertens Rep. 2011 Oct; 13(5): 378–85.
   PubMed Web of Science ®Google Scholar
• Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011 Jan; 57(1): 3–10.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurina S, Mascia S, Conte G, De Nicola L. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8 week uncontrolled trial. Am J Kidney Dis. 2007 Dec; 50(6): 908–17.
   PubMed Web of Science ®Google Scholar
• Drawz PE, Rosenthal N, Babineau DC, Rahman M. Nighttime hospital blood pressure–a predictor of death, ESRD, and decline in GFR. Ren Fail. 2010; 32(9): 1036–43.
   PubMed Web of Science ®Google Scholar
• Redon J, Plancha E, Swift PA, Pons S, Munoz J, Martinez F. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J Hypertens. 2010 Mar; 28(3): 602–07.
   PubMed Web of Science ®Google Scholar
• Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, Deo R, Fischer MJ, He J, Hsu CY, Huan Y, Keane MG, Kusek JW, Makos GK, Miller ER 3rd, Soliman EZ, Steigerwalt SP, Taliercio JJ, Townsend RR, Weir MR, Wright JT Jr, Xie D, Rahman M. Masked hypertension and elevated nighttime blood pressure in CKD: Prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4): 642–52.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010 Sep; 27(8): 1629–51.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 2011 Dec; 22(12): 2313–21.
   PubMed Web of Science ®Google Scholar
• Carter BL, Chrischilles EA, Rosenthal G, Gryzlak BM, Eisenstein EL, Vander Weg MW. Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial. J Clin Hypertens (Greenwich). 2014 Feb; 16(2): 115–21.
   PubMed Web of Science ®Google Scholar
• Rorie DA, Rogers A, Mackenzie IS, Ford I, Webb DJ, Willams B, Brown M, Poulter N, Findlay E, Saywood W, MacDonald TM. Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: The treatment in morning versus evening (TIME) study. BMJ Open. 2016 Feb 09; 6(2): e010313.
   PubMed Web of Science ®Google Scholar
• Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008 Apr; 10(4): 260–71.
   PubMed Web of Science ®Google Scholar
• Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010 Oct 11; 170(18): 1634–39.
   PubMedGoogle Scholar
• Albsoul-Younes AM, Hammad EA, Yasein NA, Tahaineh LM. Pharmacist-physician collaboration improves blood pressure control. Saudi Med J. 2011 Mar; 32(3): 288–92.
   PubMed Web of Science ®Google Scholar
• Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, Kerby TJ, Klotzle KJ, Maciosek MV, Michels RD, O’Connor PJ, Pritchard RA, Sekenski JL, Sperl-Hillen JM, Trower NK. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. Jama. 2013 Jul 03; 310(1): 46–56.
   PubMed Web of Science ®Google Scholar
• St Peter WL, Farley TM, Carter BL. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens. 2011 Sep; 20(5): 498–503.
   PubMed Web of Science ®Google Scholar
• St Peter WL, Wazny LD, Patel UD. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens. 2013 Nov; 22(6): 656–62.
   PubMed Web of Science ®Google Scholar
• Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, Singh RF, Wood Y, Kaplan RM, Mangione CM. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014 Sep 01; 36(9): 1244–54.
   PubMed Web of Science ®Google Scholar
• Mino-Leon D, Reyes-Morales H, Flores-Hernandez S. Effectiveness of involving pharmacists in the process of ambulatory health care to improve drug treatment adherence and disease control. J Eval Clin Pract. 2015 Feb; 21(1): 7–12.
   PubMed Web of Science ®Google Scholar
• Zillich AJ, Jaynes HA, Bex SD, Boldt AS, Walston CM, Ramsey DC, Sutherland JM, Bravata DM. Evaluation of pharmacist care for hypertension in the veterans affairs patient-centered medical home: a retrospective case-control study. Am J Med. 2015 May; 128(5): 539 e531–536.
   Web of Science ®Google Scholar
• Cooney D, Moon H, Liu Y, Miller RT, Perzynski A, Watts B, Drawz PE. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial. BMC Nephrol. 2015 Apr 16; 16: 56.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May; 10(5): 348–54.
   PubMed Web of Science ®Google Scholar
• Ruiz-Hurtado G, Ruilope LM, de la Sierra A, Sarafidis P, de la Cruz JJ, Gorostidi M, Segura J, Vinyoles E, Banegas JR. Association between high and very high albuminuria and nighttime blood pressure: influence of diabetes and chronic kidney disease. Diabetes Care. 2016 Oct; 39(10): 1729–37.
   PubMed Web of Science ®Google Scholar
• Ohashi N, Isobe S, Ishigaki S, Yasuda H. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res. 2017 May; 40(5): 413–22.
   Google Scholar
• Dragomir A, Cote R, Roy L, Blais L, Lalonde L, Berard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010 May; 48(5): 418–25.
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. Bmj. 2008 May 17; 336(7653): 1114–17.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, Lohr KN. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015 Jan; 175(1): 76–87.
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005 Jun; 43(6): 521–30.
   PubMed Web of Science ®Google Scholar